Total Funding
28
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 28 in past quarter
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1212604
APR is a developer of a generic version of the drug Premarin.
About the Company
APR is a developer of a generic version of the drug Premarin which is a hormone replacement drug for women.
All assets, liabilities, and intellectual property of APR were acquired by Dr. Reddy's Laboratories (New York) on July 11, 2011.